Humanized CD7 CAR-T cells
PGSDFYY 202101
Phase 2 mab active
Quick answer
Humanized CD7 CAR-T cells for T Lymphoblastic Leukemia/Lymphoma is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- T Lymphoblastic Leukemia/Lymphoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active